1Department of Obstetrics and Gynecology, Tokyo Women's Medical University, Japan.
Selective estrogen receptor modulators (SERMs) offer organ-specific benefits for osteoporosis management. Raloxifene (RLX), a SERM, shows promise in preventing fractures, comparing favorably to bisphosphonates.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: